Institute of Environmental Medicine, Karolinska Institute, Solna, Sweden.
Qual Life Res. 2010 Apr;19(3):381-90. doi: 10.1007/s11136-010-9591-y. Epub 2010 Jan 28.
Although atrial fibrillation (AF) is associated with increased morbidity and mortality from heart failure, stroke and other thromboembolic complications, there are limited data on its health-related quality of life (HRQoL) effects. The objective was to analyse the factors determining utility in patients with all types of AF, both at baseline and after 1 year from inclusion, based on data from the Euro heart survey.
HRQoL was measured with the EQ-5D questionnaire. At baseline, 5,050 patients had completed all five dimensions of the EQ-5D and 3,045 had done so after 1 year. We used Powell's censored least absolute deviations estimator for inference and ordinary least squares regressions for prediction.
Regardless of time point, utility and change in utility were significantly correlated with age, gender, AF type and symptoms. At baseline, utility was also determined by domestic status, regular exercise habits, diabetic disease and comorbidities. At follow-up, additional determinants included underlying heart disease and utility at baseline, and adverse events.
Utility in patients with AF and change over time are influenced by demographic and disease-specific variables. Our results can provide useful information on the effect of AF on QoL and input for economic evaluations.
尽管心房颤动(AF)与心力衰竭、中风和其他血栓栓塞并发症的发病率和死亡率增加有关,但关于其健康相关生活质量(HRQoL)影响的数据有限。本研究的目的是基于 Euro heart survey 的数据,分析所有类型的 AF 患者在基线时和纳入后 1 年时决定效用的因素。
HRQoL 通过 EQ-5D 问卷进行测量。基线时,5050 例患者完成了 EQ-5D 的所有五个维度,3045 例患者在 1 年后完成了这五个维度。我们使用鲍威尔的删失最小绝对偏差估计器进行推断和普通最小二乘回归进行预测。
无论时间点如何,效用及其变化与年龄、性别、AF 类型和症状显著相关。在基线时,效用还取决于家庭状况、定期运动习惯、糖尿病和合并症。在随访时,其他决定因素包括潜在的心脏病和基线时的效用以及不良事件。
AF 患者的效用及其随时间的变化受人口统计学和疾病特异性变量的影响。我们的结果可以提供有关 AF 对 QoL 的影响的有用信息,并为经济评估提供输入。